酸衍生品艾利因和艾利稳定地与α-Synuclein结合,并防止其细胞毒性聚合
S Rehan Ahmad1, Md Zeyaullah2, Abdullah M AlShahrani2
1Hiralal Mazumdar Memorial College for Women, West Bengal State University, Kolkata, West Bengal, India.
Proteins
|June 14, 2025
概括
中的化合物,包括阿利因和阿利,在抑制阿尔法-同核素聚合方面表现有前途,这是帕金森病的关键因素,具有潜在的神经保护作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 像帕金森氏症这样的神经退行性疾病涉及病态的α-synuclein聚合.
- 自然化合物为准这种聚合提供了一个治疗途径.
研究的目的:
- 为了评估来自Allium sativum的含硫化合物的潜力,以抑制α-synuclein聚合.
- 评估这些化合物的药物相似性,药理动力学特性和神经保护作用.
主要方法:
- 在分析包括ADMET分析,分子对接,分子动力学模拟和MM-GBSA结合能计算.
- 在体外验证使用SH-SY5Y基于细胞的模型进行α-synuclein聚合和细胞毒性测试.
主要成果:
- 九种化合物表现出良好的胃肠道吸收;六种化合物预计将穿越血脑屏障.
- 艾林,艾利,E-ajoene和diallyl disulfide对α-synuclein表现出强烈的结合.
- 阿林和阿利在细胞测试中显示,它们显著降低了α-synuclein聚合和细胞毒性.
结论:
- 酸衍生化合物,特别是氨酸和氨酸,是治疗alpha-synucleinopathies治疗干预的有希望的主要候选者.
- 这些化合物有效地抑制了α-synuclein聚合,并减轻了相关的神经毒性.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
547
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
547


